Federal health officials have declined to approve the psychedelic drug MDMA as a therapy for PTSD. Drugmaker Lykos ...

The US Food and Drug Administration's (FDA) decision not to approve midomafetamine-assisted therapy (MDMA-AT) for ...

Lykos Therapeutics filed an application for FDA approval of its version of MDMA-assisted therapy for PTSD in February 2024.

The Food and Drug Administration declined Friday to approve an application to treat post-traumatic stress disorder using the ...

In a previous blog on the use of psychedelics to treat mental health disorders, we reported that the US Food and Drug Administration (FDA) ...

then FDA approval of psychedelics may be a matter of “when” not “if.” MAPS Executive Director Rick Doblin has been working to legalize MDMA for PTSD since the 1980's as ... [+] well as ...

Critics addressed the elephant in the room during the FDA’s first public meeting on trauma since its decision to delay ...

It is considered to be more pleasure-inducing than other amphetamines, and for this reason, it has been a popular party drug. Some researchers call MDMA an “empathogen” or a “feeling enhancer.” PTSD ...

WASHINGTON (AP) — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a ...

MDMA came close ... should approve the drug, citing high rates of suicide among veterans with the condition. “Despite billions of federal dollars spent on addressing PTSD and mental health ...

MDMA research has been widely publicized by combat veterans, who say limited PTSD treatment options have contributed to ...